REX Peptide ETF (NASDAQ:PEPT – Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 8,874 shares, an increase of 3,844.0% from the October 15th total of 225 shares. Based on an average daily trading volume, of 7,975 shares, the short-interest ratio is currently 1.1 days. Approximately 7.4% of the company’s shares are short sold.
REX Peptide ETF Trading Up 0.5%
Shares of NASDAQ:PEPT opened at $27.92 on Thursday. The stock has a market cap of $3.35 million and a PE ratio of 6,471.95. REX Peptide ETF has a 12-month low of $25.06 and a 12-month high of $28.14.
About REX Peptide ETF
REX Peptide ETF (NASDAQ: PEPT) is an exchange-traded fund designed to provide targeted exposure to companies involved in the development, production, and commercialization of peptide-based medicines and related technologies. Rather than operating as a traditional company, the fund holds a portfolio of businesses participating in the broader peptide therapeutics industry. The fund’s investment focus may include pharmaceutical and biotechnology companies developing peptide treatments, as well as businesses supporting peptide research, drug discovery, manufacturing, delivery systems, and related healthcare applications.
See Also
- Five stocks we like better than REX Peptide ETF
- The Post-Midterm Rally Clock Is Ticking—and These 3 AI Stocks Stand Out
- Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
Receive News & Ratings for REX Peptide ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for REX Peptide ETF and related companies with MarketBeat.com's FREE daily email newsletter.
